Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

University of Salamanca at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

University of Salamanca takes part in 2 sessions at ASH 2026 in New Orleans. Its program centres on multiple myeloma. It covers BCMA-targeted bispecific antibodies from biology to real-world use, and tailoring treatment for newly diagnosed patients.

OrganizationASH 2026 Attendance
University of Salamanca
Salamanca, Spain
Universities & research institutes
Public university in Salamanca, Spain, one of Europe's oldest, with a medical school.
Symposium
Fri Dec 11
7:00am–10:00am
Anti-BCMA Bispecific Antibodies in Multiple Myeloma: From Biology to Real-World Implementation
Bispecific antibodies targeting B-cell maturation antigen in myeloma, from mechanism and resistance to trial data, outpatient dosing, and infection prevention.
Myeloma · New drugs
Symposium
Fri Dec 11
11:00am–2:00pm
Medical Crossfire®: Translating Evolving Standards of Care in Newly Diagnosed Multiple Myeloma Into Individualized Treatment Strategies
Choosing four-drug starting regimens for newly diagnosed myeloma, using residual disease tests to guide therapy, and managing new side effects.
Myeloma

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Salamanca

Tell us what you sell and we’ll find the people at University of Salamanca most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction